The mouse eggs in the various stages, of the development prior to implantation were collected and measurements were made on both the largest and smallest diameters of the vitellus, inner and outer surface of the zona pellucida. The various stages of development used were ovarian oocytes (germinal vesiA®e stage), ovulated but unfertilized egg, ovulated and fertilized egg, the 2-cell embryo on the second day of pregnancy, 4-8-cell embryo on the third day of pregnancy and morulablastocyst on the fourth day of pregnancy, A further comparative study on unfertilized and fertilized tubal eggs was made, The time of l2 hours after H.C.G. injection was chosen as the starting point from which to follow the collection of eggs every 3 hours for 24 hours. Since the volume gives a better comparison of size than diameter, the volume of the total eggs, intrazonal cavity, perivitelline space and the various were calculated for the various preimplantation stages of mouse egg. The volume of zona pellucida was also calsulated by subtraction of the volume of the inner zonal cavity from the volume of total egg and compared with the zona pellucida thickness. All calculations were made by computor(CEIR Time-sharing Computor). The diameter and volume of the vitellus in the ovarian oocyte is the largest one of any stage during the preimplantation stages of development, while the total volume of the entire egg as determined from the diameter of outer surface of the zona pellucida of the ovarian cocyte is the smallest one of any stage during development. The diameter and total volume of the entire egg increases from the ovarian oocytes to the first day of pregnancy and then gradually decreases until the third day of pregnancy. An increase in these parameters again takes place on the fourth day of pregnancy. The zona pellucida of the tubal ova is thicker than that of the oocyte, with the zona pellucida of the fertilized egg being definitely thinner when compared with unfertilized eggs. This phenomenon of decreased thickness in fertilized egg may be associated with zona reaction. The perivitelline space between the vitellus and zona pellucida thus formed following ovulation occupied approximately 40 percent of the total volume enclosed by the inner surface of the zona pellucida (intrazonal cavity) in the 1-cell tubal ova. Neither the cause of the rapid accumulation of fluid after ovulation which resulted in the production of the perivitelline space nor the actual time of the formation of the perivitelline space are known. Some possible reasons for the formation or origin of the perivitelline space are discussed. The size and shape of the vitellus undergo compartive reduction during preimplantation stages of development. The possible reason for the reduction of vitelline volume are discussed.
Animal ; Blastocyst ; Embryo/cytology* ; Embryo Implantation ; Embryo and Fetal Development ; Female ; Fertilization ; Mice ; Ovulation ; Ovum/cytology ; Ovum/growth & development ; Temperature ; Time Factors

The ultrastructural changes of mitochondria in the ovarian oocytes from Graafian follicles, the ovulated tubal ova, and the various stages of preimplantation rabbit embryos have been observed with an electron microscope. From the ovarian oocytes to the 4-cell stage, mitochondria showed oval and round forms with a few cristae arranged concentrically and peripherally at the inner membrane. In 8-cell and 16-cell stages, mitochondria tended to change their forms to be elongated, and their sizes, and the outer membrane of the mitochondria had a tendency to become rough and irregular although there were few changes in the inner structure. In morula, some mitochondria began to show several transverse cristae proceeding into the matrix. Mitochondria rapidly increased in number at the late blastocyst stage. Matrix of mitochondria with transverse cristae found in the morula and in blastocyst stages was less dense than that of the earlier stages. The authors believe that the morphological changes of mitochondria during early embryonal development indicate the level of enzymatic activity at which this organelle is engaged in energy metabolism.
Animal ; Cell Membrane/ultrastructure ; Embryo/ultrastructure* ; Embryo Implantation ; Female ; Microscopy, Electron ; Mitochondria/ultrastructure* ; Organoids/ultrastructure ; Ovum/ultrastructure ; Rabbits

No abstract available.
Animals ; Embryo Implantation* ; Embryonic Structures* ; Female ; Mice* ; Pregnancy

Abdominal pregnancy is one of the rare but extremely harzardous complications of childbearing. The diagnosis of the abdominal pregnancy is rarely made before surgery and the management of it also has many difficult problems. I experienced a case of abdominal pregnancy developed after the previous unilateral adnexectomy and it was a suspicious primary abdominal pregnancy as though did not fulfilled the Studdiford's the following criteria for primary abdominal pregnancy. 1) Normal tubes and ovaries with no evidence of recent or remote injury, 2) absence of any evidence of uteroplacental fistula, and 3) presence of a pregnancy related exclusively to the peritoneal surface and young enough to eliminate the possibility of secondary implantation following primary nidation in the tube. And now I present a case with brief review of literatures.
Diagnosis ; Embryo Implantation ; Female ; Fistula ; Ovary ; Pregnancy ; Pregnancy, Abdominal*

OBJECTIVE: To investigate the impact of fibroids on the blood flow of the uterine and subendometrial arteries and in vitro fertilization (IVF) outcomes. METHODS: In this study, we analyzed 86 IVF/intracytoplasmic sperm injection (ICSI) cycles in which a gonadotropin-releasing hormone antagonist protocol was used for controlled ovarian stimulation between January 2008 and March 2009. The subjects comprised 86 infertile women with (fibroid group, n=43) or without (control group, n=43) uterine fibroids. RESULTS: Patient characteristics were similar between the fibroid and control groups. The IVF/ICSI outcomes in patients with fibroids were similar to those of patients in the control group. The resistance index (RI) and pulsatile index (PI) of the uterine and subendometrial arteries on the day of embryo transfer were also comparable between the two groups. IVF outcomes and uterine hemodynamics in patients with multiple (> or =2) fibroids were similar to those of patients with a single fibroid. However, clinical pregnancy and implantation rates were significantly lower in patients with fibroids who experienced uterine cavity distortion than in patients with fibroids who had a normal uterine cavity (both p<0.05). The RI and PI of the subendometrial artery were significantly higher on the day of embryo transfer in patients with fibroids who experienced uterine cavity distortion than in patients with fibroids who had a normal uterine cavity (both p<0.05). CONCLUSION: Fibroids which distorting the uterine cavity might impair the subendometrial artery blood flow clinical pregnancy rate and embryo implantation rate in infertile patients undergoing IVF. Otherwise, IVF outcomes were not influenced by the presence of uterine fibroids.
Arteries ; Embryo Implantation ; Embryo Transfer ; Female ; Fertilization in Vitro* ; Gonadotropin-Releasing Hormone ; Hemodynamics* ; Humans ; Leiomyoma* ; Ovulation Induction ; Pregnancy ; Pregnancy Rate ; Spermatozoa

OBJECTIVE: To evaluate whether the surgical resection or aspiration with ethanol sclerotherapy (AEST) of endometrioma before in vitro fertilization (IVF) affect controlled ovarian stimulation (COS) and IVF outcome in the infertilie women with endometroma undergoing IVF. METHODS: In this retrospective cohort study, 101 consecutive IVF/intracytoplasmic sperm injection cycles that were performed in 101 patients with endometrioma(s) between January 2008 and December 2012 were included. Before IVF, 36 patients underwent surgical resection of endometrioma (resection group), 29 patients had transvaginal endometrioma AEST (aspiration group), and 36 patients did not take any surgical intervention (control group). The three groups were compared in terms of COS and IVF outcomes. RESULTS: Total antral follicle count was significantly lower in the resection group than in the aspiration or control group. The numbers of follicles with a diameter of 14 to 17 mm on the human chorionic gonadotropin day, retrieved oocytes, mature oocytes, and fertilized oocytes were significantly lower in the resection group than in two other groups. However, three groups were similar in terms of clinical pregnancy rate (CPR) per initiated cycle, CPR per embryo transfer, embryo implantation rate, and miscarriage rate. CONCLUSION: Neither of surgical resection and AEST of endometrioma before IVF treatment can give any beneficial effect on IVF outcomes. Moreover, surgical resection of endometrioma can affect the ovarian reserve and ovarian response during COS.
Abortion, Spontaneous ; Cardiopulmonary Resuscitation ; Chorionic Gonadotropin ; Cohort Studies ; Embryo Implantation ; Embryo Transfer ; Endometriosis* ; Ethanol* ; Female ; Fertilization in Vitro* ; Humans ; Oocytes ; Ovulation Induction ; Pregnancy ; Pregnancy Rate ; Retrospective Studies ; Sclerotherapy* ; Spermatozoa

Since first introduction of oral contraceptive pills in 1960, with increased women's right of sexual decision, oral contraceptives had been used widely around the globe as a highly effective and safe contraceptive method. The physiological mechanisms of oral contraceptives were a reduced maturation of ovarian follicles and blocked ovulation to fertile women. Also, oral pills induce uterine endometrial decidualization, thickening of cervical mucus, disturbance of intrauterine sperm movement and embryo implantation. However, in addition to providing effective reversible contraception to fertile women, oral contraceptive pills offer various non-contraceptive benefits to numerous conditions. In this review, we summarize the list of currently available oral contraceptive pills in Korea and discuss non-contraceptive indications of oral contraceptives pills.
Cervix Mucus ; Contraception ; Contraceptives, Oral* ; Embryo Implantation ; Female ; Humans ; Korea ; Ovarian Follicle ; Ovulation ; Pregnancy ; Spermatozoa ; Women's Rights

OBJECTIVE: To evaluate whether letrozole incorporated in a gonadotrophin-releasing hormone (GnRH) antagonist multiple dose protocol (MDP) improved controlled ovarian stimulation (COS) and in vitro fertilization (IVF) results in poor responders who underwent IVF treatment. METHODS: In this retrospective cohort study, a total of 103 consecutive IVF cycles that were performed during either the letrozole/GnRH antagonist MDP cycles (letrozole group, n=46) or the standard GnRH antagonist MDP cycles (control group, n=57) were included in 103 poor responders. COS results and IVF outcomes were compared between the two groups. RESULTS: Total dose and days of recombinant human follicle stimulating hormone (rhFSH) administered were significantly fewer in the letrozole group than in the control group. Duration of GnRH antagonist administered was also shorter in the letrozole group. The number of oocytes retrieved was significantly higher in the letrozole group. However, clinical pregnancy rate per cycle initiated, clinical pregnancy rate per embryo transfer, embryo implantation rate and miscarriage rate were similar in the two groups. CONCLUSION: The letrozole incorporated in GnRH antagonist MDP may be more effective because it results comparable pregnancy outcomes with shorter duration and smaller dose of rhFSH, when compared with the standard GnRH antagonist MDP.
Abortion, Spontaneous ; Aromatase* ; Cohort Studies ; Embryo Implantation ; Embryo Transfer ; Female ; Fertilization in Vitro* ; Follicle Stimulating Hormone, Human ; Gonadotropin-Releasing Hormone ; Humans ; Oocytes ; Ovulation Induction ; Pregnancy ; Pregnancy Outcome ; Pregnancy Rate ; Retrospective Studies

OBJECTIVE: To evaluate the effect of progesterone supplementation during the luteal phase on pregnancy outcome in natural frozen-thawed embyo transfer (FTET) cycles. METHODS: In this retrospective cohort study, 228 consecutive patients who underwent FTET cycles between January 2009 and September 2012 were included. One hundred forty-five patients received luteal progesterone support (P group) but 83 patients did not receive any progesterone supplementation during luteal phase (control group). RESULTS: There were no differences in patients' characteristics between the two groups. The two groups were similar with respect to the characteristics of previous fresh in vitro fertilization cycle in which embryos were cryopreserved including the numbers of oocytes retrieved, mature oocytes, fertilized oocytes, grade 1 or 2 embryos and frozen embryos. Also, significant differences were not observed between the P and control groups in clinical pregnancy rate, embryo implantation rate and multiple pregnancy rate. However, miscarriage rate was significantly lower in the P group and live birth rate was significantly higher in the P group than in the control group (P<0.05, P<0.05). CONCLUSION: Our results suggest that luteal phase progesterone supplementation decreases miscarriage rate and improves live birth rate in natural FTET cycles.
Abortion, Spontaneous ; Cohort Studies ; Embryo Implantation ; Embryo Transfer* ; Embryonic Structures ; Female ; Fertilization in Vitro ; Humans ; Live Birth ; Luteal Phase* ; Oocytes ; Pregnancy ; Pregnancy Outcome ; Pregnancy Rate ; Pregnancy, Multiple ; Progesterone* ; Retrospective Studies

OBJECTIVE: Uterine contraction induced by the embryo transfer (ET) process has an adverse effect on embryo implantation. The aim of this study was to determine the effect of oxytocin antagonist supplementation on the day of ET on in vitro fertilization outcomes via a meta-analysis. METHODS: We performed a meta-analysis of randomized controlled trials (RCTs). Four online databases (Embase, Medline, PubMed, and Cochrane Library) were searched through May 2015 for RCTs that investigated oxytocin antagonist supplementation on the day of ET. Studies were selected according to predefined inclusion criteria and meta-analyzed using RevMan 5.3. Only RCTs were included in this study. The main outcome measures were the clinical pregnancy rate, the implantation rate, and the miscarriage rate. RESULTS: A total of 123 studies were reviewed and assessed for eligibility. Three RCTs, which included 1,020 patients, met the selection criteria. The implantation rate was significantly better in patients who underwent oxytocin antagonist infusion (19.8%) than in the control group (11.3%) (n=681; odds ratio [OR], 1.92; 95% confidence interval [CI], 1.25–2.96). No significant difference was found between the two groups in the clinical pregnancy rate (n=1,020; OR, 1.57; 95% CI, 0.92–2.67) or the miscarriage rate (n=456; OR, 0.76; 95% CI, 0.44–1.33). CONCLUSION: The results of this meta-analysis of the currently available literature suggest that the administration of an oxytocin antagonist on the day of ET improves the implantation rate but not the clinical pregnancy rate or miscarriage rate. Additional, large-scale, prospective, randomized studies are necessary to confirm these findings.
Abortion, Spontaneous ; Embryo Implantation ; Embryo Transfer* ; Embryonic Structures* ; Female ; Fertilization in Vitro* ; Humans ; In Vitro Techniques* ; Odds Ratio ; Outcome Assessment (Health Care) ; Oxytocin* ; Patient Selection ; Pregnancy ; Pregnancy Rate ; Prospective Studies ; Uterine Contraction